Embryonic stem cells have the ability to differentiate into nearly all cell types. However, the molecular mechanism of its pluripotency is still unclear. Oct3/4, Sox2 and Nanog are important factors of pluripotency. Oct3/4 (hereafter referred to as Oct4), in particular, has been an irreplaceable factor in the induction of pluripotency in adult cells. Proteins interacting with Oct4 and Nanog have been identified via affinity purification and mass spectrometry. These data, together with iterative purifications of interacting proteins allowed a protein interaction network to be constructed. The network currently includes 77 transcription factors, all of which are interconnected in one network. In-depth studies of some of these transcription factors show that they all recruit the NuRD complex. Hence, transcription factor clustering and chromosomal remodeling are key mechanism used by embryonic stem cells. Studies using RNA interference suggest that more pluripotency genes are yet to be discovered via protein-protein interactions. More work is required to complete and curate the embryonic stem cell protein interaction network. Analysis of a saturated protein interaction network by system biology tools can greatly aid in the understanding of the embryonic stem cell pluripotency network.
Introduction
Embryonic stem (ES) cells were successfully isolated from the mouse in 1981. Two landmark papers opened the doors to this new source of cells that was to become as important as, if not more important than, HeLa cells to medical science. ES cells are derived from the inner cell mass of the blastocyst stage embryo (1, 2) . Under the appropriate conditions, these cells replicate indefinitely. Yet unlike other immortalized cell culture, ES cells show a normal karyotype. In addition to their ability to replicate indefinitely, these cells demonstrate *Electronic supplementary material to this article with the DOI 10.1515/BMC.2011.008SUP is available from the journal's online content site at www.reference-global.com/toc/bmc/2/1-2.
pluripotency. Pluripotency is the ability to differentiate into almost all cell types (including the trophectoderm which is sometimes excluded in definitions), without the ability to organize into a whole organism (3) (4) (5) .
The main thrust for ES cell research comes from its prospects in biomedical research (6) , namely, the promises of tissue replacement and regeneration, also referred to as regenerative medicine or regenerative therapy. There are different approaches towards this goal. The two most direct approaches are: (i) to use human ES cells to generate clinically relevant cell populations; and (ii) to use molecular factors to induce pluripotency in adult cells. The product is an induced pluripotent stem (iPS) cell that is then used to generate desired tissues via differentiation. In these approaches, understanding the molecular basis of pluripotency is fundamental. This review will address the protein determinants of pluripotency in ES cells. Recent efforts on the construction of ES cell protein interaction networks and conclusions derived from such data on the molecular mechanism of pluripotency are also covered.
The protein determinants of pluripotency
Since the isolation of ES cells, the focus has advanced to looking for protein determinants of the pluripotent state. Transcription factors play key roles in setting up the embryonic cells for pluripotency because they control gene expression. Three transcriptional factors, Oct4, Sox2 and Nanog, have been identified as key factors in the regulation of pluripotency (4, 7) .
Oct4 is considered an important protein for pluripotency because it is an irreplaceable factor in the reprogramming of differentiated cells into iPS cells (8) . It was found as a DNAbinding protein that is exclusively expressed during the earliest stages of embryonic development (9) (10) (11) (12) (13) (14) . Needless to say, Oct4 is expressed in ES cells. Oct4 null mouse embryos reach the blastocyst stage but the inner cell mass is not pluripotent (15) , instead these cells become restricted to the trophoblast lineage.
Sox2 was discovered as a transcription factor that often bound next to the Oct4 motif (16) . Sox2 null mouse embryos have an inner cell mass but with the depletion of maternal Sox2, these embryos fail to maintain the epiblast (16) . The importance of the discovery of Sox2 is its interaction with Oct4. Sox2 collaborates with Oct4 to activate Fgf4, a gene that is expressed in the inner cell mass and later in distinct embryonic tissues (17, 18) . Direct protein-protein interaction between the two transcription factors was shown using a bacterially expressed Oct4-GST fusion protein and in vitro- (20) . Subsequently, Oct4 and Sox2 collaboration was also found to regulate expression of Utf1 (21), Fbx15 (22) and Nanog (23) . In addition, the enhancer elements of Oct4 and Sox2 were also found to contain the Oct4-Sox2 binding elements, suggesting that protein-protein interaction is also a mechanism for autoregulation (24) (25) (26) . In addition to Oct4 and Sox2, the finding that other transcription factors also show clustering at ES cell-specific genes (27, 28) further support the potential of protein-protein interaction as a code for transcriptional activation. Systematic high-throughput methods further propelled the search for pluripotency factors. Nanog was discovered by two such approaches. The first approach used digital differential display of expressed sequenced tags in mouse ES cells versus somatic tissue (29) . The second approach screened cDNA library-transfected ES cells for colonies that remained undifferentiated in the absence of LIF (30) . Nanog null mouse embryos have the inner cell mass at the blastocyst stage but it fails to become the epiblast and instead differentiates into parietal endoderm-like cells (29) .
The strong evidence for the involvement of Oct4, Sox2 and Nanog in pluripotency makes them good starting points (nodes) to study the protein interaction network of pluripotency. In addition, de novo discovery of genes with functional association to pluripotency comes from RNA interference (RNAi) studies. Several studies including two genome-wide screens led to the identification of a total of 167 pluripotency-associated genes (Table 1) including Oct4, Sox2 and Nanog (31) (32) (33) (34) . Out of these 167 proteins, only 15 (Table 1) are currently connected to the Oct4-centered protein interaction network (shaded in grey).
It is envisaged that all of these proteins, particularly factors that have been validated will be nodes in the pluripotency protein interaction network.
Building the ES cell protein interaction network
As more molecular determinants of pluripotency become defined, the next challenge is to integrate them into meaningful mechanisms. Network formulation is useful for the management and understanding of complex mechanisms (35) . One type of network is the protein interaction network. A protein interaction network comprises proteins as nodes and undirected edges as the occurrence of binding. The datasets that are used to build the ES cell protein interaction network is generated via affinity purification-mass spectrometry methods of experimentation, and the datasets are mostly Oct4-centric because of its importance in ES and iPS cells. Currently, there are four studies using Oct4 as the 'bait' to find pluripotency-associated proteins (36) (37) (38) (39) . Other proteins that have been used as baits include Nanog, Sall4, Tcfcp2l1, Dax1, Esrrb, Rex1, Nac1 and Zfp281, all of which also showed interaction with Oct4. Integrating these studies gives (Table 2 ). Of these, 131 proteins (Table 2) were associated with Oct4. Building the network brings new questions on the completeness and the accuracy of the data. How much of the interactions are we missing? How many false positives are included?
The concern on 'missing interactions' is most strikingly illustrated by the absence of Nanog and Rex1 when Oct4 was the bait (Table 2) . Particularly, there are several studies that show association of Oct4 and Nanog (38) (39) (40) . One reason for the non-reciprocal results could be the different protein levels between Nanog and Oct4 in ES cells. Nanog exists at lower levels than Oct4 making it harder to detect The bait protein used includes Oct4, Nanog, Sall4, Tcfcp2l1, Dax1, Esrrb, Rex1, Nac1 and Zfp281. Proteins found when Oct4 was the bait are shaded grey. *Nanog and *Zfp42 (Rex1) interacts with Oct4 when they are used as the bait. A total of 167 genes were found in four separate RNAi studies. A total of 240 proteins were found via protein-protein interaction with Oct4, Nanog, Sall4, Tcfcp2l1, Dax1, Esrrb, Rex1, Nac1 and/or Zfp281. Between the two approaches, only 15 genes/proteins are in common.
Nanog in Oct4 purifications. Conversely, Oct4 exists at higher levels than Nanog and is therefore more easily detected in Nanog purifications. This example suggests that important interactions could be missed for proteins expressed at low levels, as are many transcription factors. Further evidence that a large part of the network remains to be uncovered comes from the low overlap between the components identified from protein-protein interaction and from genome-wide RNA interference studies (Figure 1 ). The incomplete overlap between the different groups that all study protein-protein interactions (Figure 2 ) also supports this belief. Alternatively, only the intersection represents true Oct4 interacting proteins (41) . However, the observation of interactors such as Sox2 outside the intersection (Figure 2 ) supports the former opinion rather than the latter. Certainly, the network is not free of inaccuracies. The weak-yet-important interactions make the distinction of 'false positive' an even greater challenge than it already is. The main challenge comes from the low throughput nature of available validation methods and the shortcomings of each of them.
The most direct method of validating a protein-protein interaction is via reciprocal co-precipitation. This is frequently done by overexpressing the two proteins in a cell culture system. However, some proteins interact indirectly via a common protein, which if not present in the cell, would yield negative results in a co-precipitation analysis.
Furthermore, after direct or indirect association has been verified, it is important to examine the functional significance of proteins in the network. Not all physical association has functional significance. For example, both Oct1 and Oct4 can interact with Sox2, but only the Oct4-Sox2 complex can activate Fgf4 expression (18) . Hence, multiple validations are important. Validations that have been employed are as follows: (i) evidence for presence of the interacting protein in ES cells; (ii) evidence that interacting proteins coexist in a common subcellular location; (iii) indication that the level of abundance of the interacting protein changes upon differentiation; (iv) indication that the interacting protein regulates genes of known ES cell transcription factors or vice versa; (v) gain or loss of pluripotency of ES cells when the gene of the interacting protein is knocked-out, suppressed by RNAi or overexpressed. Pluripotency can be monitored by alkaline phosphatase staining, ES cell morphology, transcript levels of Oct4 or Nanog, profiling of lineage markers, and the levels of stage-specific embryonic antigen 1, 3 and 4; and (vi) loss-of-function phenotypes in mice when the gene of the interacting protein is knocked-out, suppressed by RNAi or overexpressed. Given that gene redundancy or functional redundancy is a phenomenon of pluripotency (42) , validations that show no effect with a single gene knock-out could be further evaluated via double or triple knock-outs.
Certainly, efforts to extend the boundaries of the ES cell protein interaction network via iteration (36, 39) would help to complete the protein interaction network. However, care should be taken not to go off-tangent in this approach, particularly if protein interaction networks are not truly separable modules in the cell. Yeast 2-hybrid is an alternative approach. However, this approach appears to yield a significantly lower number of Oct4-interacting proteins (38) compared to tandem affinity-mass spectrometry. This would suggest that Oct4 does not show strong binary interactions and rather could be relying on DNA-enhanced associations or complex-mediated indirect associations. Although more research would be required to confirm this, this postulation is corroborated by the observation of its weak interactions with Nanog and Sox2.
Eventually, stricter definitions will be required to trim the ES cell protein interaction network to reveal the core mechanism of pluripotency. This could entail the distinction between genes that control pluripotency and genes that regulate differentiation. Loss of a 'differentiation' gene could appear as a loss of pluripotency because the ES cell would no longer show the ability to differentiate into its normal repertoire of cell types. However, such defects can be corrected with the reexpression of the gene, suggesting that the pluripotent state is there all the time (7). As proteins tend to demonstrate multifunctionality, it would also be necessary to validate the role of specific interactions rather than components in pluripotency.
Mining the network
There are different levels of analysis in a protein interaction network. A basic analysis is the identification of novel components. Protein-protein interactions added another 225 pluripotency-associated components to those found via RNAi (Figure 1) . Ideally, via an iterative approach of protein-protein interaction, all the pluripotency-associated genes identified by RNAi should be rediscovered.
To understand the molecular mechanism of pluripotency, different methods have been employed. Firstly, to unearth key controllers, transcription factors are identified using the Gene Ontology annotation GO:0003700, which is proteins with sequence-specific DNA binding transcription factor activity or other closely related terms. Based on the integrated dataset of all four protein-protein interaction studies, and the annotation 'transcription factor' used in these studies, there are a total of 77 transcription factors. Figure 3A shows (A) The mouse network is constructed based on transcription factors interacting with pluripotency-associated factors, Oct4, Nanog, Sall4, Dax1, Esrrb, Tcfcp2l1, Nac1, Zfp281 and Zfp42 (alias Rex1) (36) (37) (38) (39) . Oct4 is marked yellow. Transcription factors interacting with more than one other transcription factor (inside the circle) could represent the phenomenon of transcription factor clustering for the activation of ES cell genes. For two studies (38, 39) , names of proteins were updated to the official one (with the original names used in the publication in parentheses) so that they are consistent across all the studies. Protein functions where not given were also annotated based on gene ontology so that they are consistent across these studies. The compiled list is shown in Supplementary Table S1 . From this list, proteins which are transcription factors are selected to generate a protein interaction network. (B) The human network is constructed based on transcription factors that were found via RNAi to have a role in pluripotency (43) . The human ortholog of mouse Oct4 is POU5F1 and is marked yellow. A total of 67 transcription factors were uploaded to the online database STRING to search for possible interactions. These interactions are predicted based on experimental as well as homology-based evidences. Both the mouse and human networks are constructed by Cytoscape 2.8.0 (67) and visualized using the force-directed paradigm called spring embedded Cytoscape Layout. a protein-interaction network of these transcription factors using datasets from all four studies. Because clustering of transcription factors on promoters is observed in ES cells, protein-protein interaction between these transcription factors could provide combinatorial codes required for regulation of gene expression for pluripotency. Presumably, transcription factors with two or more interactions ( Figure  3A , inside the circle) would be activating more ES cell-spe- Table S1 . Edges between the five transcription factors Sall4, Esrrb, Nanog, Oct4 and Tcfcp2l1 are replaced by direct contacts of the nodes to suggest colocalization of these transcription factors. Nodes of proteins belonging to the NuRD complex are merged to suggest their entity as a macromolecule.
cific genes. Whereas transcription factors with one interaction ( Figure 3A , outside the circle) could be activating more general genes. Certainly, there are transcriptions factors that are important to pluripotency but do not cluster into the circle of highly interactive zone because the network is incomplete. For example, the Sox2-interactome has yet to be reported by any lab. The current network therefore serves as a guide for further research.
On this note, this mouse network can also serve as a comparison for data on human embryonic stem cells. Determinants of human embryonic stem cell pluripotency have been identified by a genome-wide RNAi screen (43) . The screen identified a total of 566 genes and a protein interaction network based on these has been reported. To compare the transcription factor protein interaction network of mouse and human, we constructed a protein interaction network based solely on the transcription factors, which numbers 67 in the 566 genes. Because the approach of affinity purificationmass spectrometry is yet to be applied to human embryonic stem cells, information regarding possible interactions between any of the 67 transcription factors was obtained via the online database STRING. This results in a network which was reconstructed using Cytoscape ( Figure 3B ). Clearly, in contrast to the mouse network, most of the transcription factors were unconnected, probably owing to a lack of understanding of these transcription factors. POU5F1, a crucial transcription factor to human ES cell pluripotency, is also highly unexplored with regard to its protein-protein interactions. The only POU5F1 interaction shown in Figure 3B is inferred by studies from mouse ES cells where Oct4 was shown to physically interact with Zscan10 (alias Zfp206) (44) . Connections between POU5F1 and SOX2 and between POU5F1 and NANOG cannot be drawn because these genes did not pass the criteria in the RNAi screen for genes that maintain pluripotency in the human ES cells. This suggests that mouse and human pluripotency determinants are highly diverged. It is therefore imperative to investigate the protein interaction network for human ES cells, particularly using POU5F1 as bait.
Secondly, to understand the mechanisms employed by the transcription factors, proteins can be categorized into any of the three gene ontology sections: (i) molecular function; (ii) biological process; and (iii) cellular components (45) . Annotations under biological process can help understand the role of a local network of proteins. Annotations under cellular components are extremely useful for the identification of multisubunit enzymes or protein complexes. Presence of all the components of a protein complex is a strong indication that the machinery is assembled for use. It should be noted that proteins can have multiple functions; hence, the assignment of a novel function should be considered if a component is not copurifying with the rest of the complex.
Using the method of gene ontology annotation, it was found that the nucleosome remodeling histone deacetylase (NuRD) complex (46) is the most prominent complex identified in the ES cell protein-interaction network (36) (37) (38) . All the components of this complex are found in the network and each of the components interacts with one or more of the five transcription factors which have been studied in greater detail (36) . These include Nanog, Esrrb, Oct4, Tcfcp2l1 and Sall4 (Figure 4 ) which are themselves tightly associated with one another. Because some of these transcription factors have been proven to have a direct role in pluripotency, it can be concluded that the ES cell utilizes histone deacetylation mediated by NuRD as a gene repression mechanism to regulate pluripotency. Indeed, case studies have shown that NuRD has specific developmental roles rather than being required for general cellular functions (46) (47) (48) . In addition to NuRD, other complexes have been reported in the study by Pardo and colleagues (37) . Most of these are involved in chromosome remodeling. Confirmation of these findings would surely expand our knowledge of the extent to which each of these complexes contributes to pluripotency. For example, there is evidence that chromosomal remodeling factors such as the polycomb group and polycomb repressive complex are not required for maintenance of pluripotency in ES cells (4, (49) (50) (51) (52) (53) (54) . Although it is believed that these repressors serve to prevent spontaneous differentiation of the ES cells, the chromatin of the ES cell is deemed, at the same time, to be relatively 'loose' so as to allow free accessibility to the transcription factors. Having the different chromatin modifiers inserted into the protein interaction network can help to clarify their role in pluripotency. In addition to the chromatin modifiers, the basic transcriptional machinery was also found to be recruited to the protein interaction network by Esrrb (36) . However, this mechanism appears not to be utilized by the other transcription factors in the network. It remains unclear if this mechanism is directly related to the regulation of pluripotency.
A third method that is yet to be fully utilized for the analysis of the protein interaction networks is to employ the tools of system biology. This is because the protein interaction network is currently incomplete. At this stage, the network structure can be strongly skewed by the methods used to generate the network (55) . The observation that essential proteins tend to be more highly connected than nonessential proteins could also be a true property or a consequence of them having been more thoroughly studied, or a combination of the two (56) . However, as data accumulates, the power of systems biology to catalogue and integrate data will be necessary (35) . Concepts from graph theory (35, 57, 58) can provide us with insight into the 'molecular characteristic' or the 'functional characteristic' of the ES cell. Simulations can be used to allow us to predict and explain the outcomes of experimental manipulations.
The future network
A protein interaction network by virtue of the protocols employed is a single snapshot of the protein-protein interactions of the cell at any given time. To understand how ES cells have the ability to differentiate into different cell types, further information will have to be integrated. The final protein interaction network should include information on protein subcellular location and protein concentration. For example, ES cell fate has been shown to be highly sensitive to Oct4 dosage levels (59) . All information in the network will change as a function of time as the cell undergoes cell cycling and when the cell undergoes fate changes. A study on the systems level changes across the three mechanistic layers: epigenetic, transcriptional and translational during fate change in mouse ES cell data show that changes in nuclear protein levels are not accompanied by concordant changes in the corresponding mRNA levels, suggesting that translational and post-translational mechanisms, rather than transcriptional regulation, play important roles during lost of pluripotency (60) . For full understanding and successful simulation, information from the protein interaction network, the gene regulatory network and microRNA networks of ES cells should be fed back into one another. Ultimately, the goal of using systems biology is to be able to show how the properties of individual components collaborate into a meaningful integrated process, and how the different processes result in the emergent property of pluripotency.
Expert opinion
Ironically, pluripotency is best demonstrated by its loss. A population of cells is pluripotent if it can differentiate into many cell types; but once that happens, pluripotency is lost. In the ES cell, molecules for pluripotency work to balance two opposing features: the readiness to initiate differentiation and the prevention of differentiation. To understand the molecular mechanism of pluripotency, we need to keep in mind this concept of pluripotency.
The current protein interaction network encompasses both of these features of pluripotency. To complicate matters, most proteins are multifunctional and can play different roles in both aspects of pluripotency. In view of this, looking at proteins for the assignment of processes can be more confusing than helpful. Assignment of processes can be more meaningful if it is done to the edges of the network rather than to the nodes. This opinion can be best illustrated with an example. The readiness to differentiate is established by keeping the chromatin in an accessible state. This can be achieved by close cooperation between chromatin modifiers and transcription factors such as Oct4. Hence, the edge between the Oct4 node and the NuRD protein nodes can be assigned with the purpose of 'keeping chromatin relaxed'. For the prevention of differentiation, one mechanism is via protein-protein interaction of transcription factors and again Oct4 can be involved. For example, physical interaction between Oct4 and Cdx2 forms a repressor complex which provides autoregulation of the two genes. Furthermore, physical interaction between Oct4 and Sox2 forms an activation complex for the transcription of genes such as Fgf4. Hence, the edges between Oct4 and other transcription factors can be assigned with the purpose of 'auto-repressor' and 'compulsory co-activation', respectively.
Another perspective which should be incorporated when looking at the protein interaction network is the presence of two types of protein-protein interactions. Transient proteinprotein interactions occur between transcription factors or between transcription factors and other protein complexes. Static protein-protein interactions occur between protein subunits of a stable protein complex. The first type of interaction usually encodes instructions or messages, whereas the second type of interaction functions mainly to execute the processes as a module. Identifying these interactions allow us to understand how cell fate decisions are made and how these decisions are executed.
In view of the large number of proteins that have been associated with pluripotency. It is possible that there are alternate means of achieving pluripotency. After all, pluripotency is a cellular state rather than a cellular composition. Proteins such as Ronin (61, 62) , which show strong associations with pluripotency, can operate via a separate network. Observations that different combinations of factors (8, (63) (64) (65) (66) can also induce pluripotency are another sign of the multiple means of achieving this state.
Overall, we envisage great promise in obtaining answers and insights from a mature protein interaction network. However, this will require construction of the network to be closely accompanied with attempts to annotate the purpose and nature of the interaction as discussed above.
Outlook
An example of how knowledge derived from mouse ES cells has contributed towards the goal of regenerative stem cell therapy is the generation of iPS cells. The factors discovered from ES cells were used to induce pluripotency in adult cells. This removes the need to use human embryos which is highly controversial in stem cell therapy. In the next 10 years, ES cells will continue to be a source of guidance until iPS technology is perfected. During this time, data accumulation should continue until a point where the boundaries of the protein interaction network are felt. At the same time extra efforts will be needed towards looking for interactions among low concentration proteins and towards validation of the network. With a more complete protein interaction network, new hypothesis can be formulated. As more system biology data is generated from other fields, it will become possible to compare between non-pluripotent and pluripotent networks. The ES cell protein interaction network, once ready, will serve as a point of comparison with other stem cells, with differentiating cells and with cancer cells. Such comparisons can potentially bring out unique features of operation in each of these cellular conditions. Finally, in view of the differences between human and mice, the same work will have to be repeated with human ES cells. However, from the challenges encountered in mouse ES cell research, the working knowledge gained will ensue much faster progress with the human ES cell project.
Highlights
• Three transcription factors, Oct4, Sox2 and Nanog, show strong evidence in their role as determinants of pluripotency.
• Another 237 proteins are associated with these determinants by protein-protein interactions.
• Another 152 proteins discovered to have a role in pluripotency by genome-wide RNAi screening are yet to be connected via protein-protein interactions.
• Further protein-protein interaction studies to connect and extend on these proteins are necessary.
• Multiple validations to confirm the involvement of these proteins in pluripotency are necessary.
• Transcription factors show collaboration in the protein interaction network.
• NuRD is frequently recruited by a core of ES cell transcription factors.
• Other chromatin modification machineries are also potentially recruited.
• When the network is reasonably saturated, system biology analysis should be employed to give insight into network properties.
• Assignment of purpose to edges rather than to nodes in the network will drive understanding of the network.
• Inclusion of information on dynamic properties of the protein interaction network would facilitate predictive capabilities.
